All systems operational
Q1 2024

Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors

Iqra Saleem Naz Babari · Muhammad Islam · Hamid Saeed · Humaira Nadeem · Hassaan Anwer Rathore
10.1016/j.jsps.2024.102191 392 Views 5 Citations
5
Citations
392
Views
Abstract not available for this publication.
Cite this Article (APA)
Iqra, S. N. B., Muhammad, I., Hamid, S., Humaira, N., Hassaan, A. R. (2024). Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102191
Related Papers
Human plasma derived exosomes: Impact of active and passive drug loading approaches on drug delivery
Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024
40
cites
395
Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems
Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024
30
cites
391
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities
Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024
26
cites
394
Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …
Faisal Imam; Sayantan Mukhopadhyay; Preeti Kothiyal; Samiyah Alshehri; Khalid Sa · 2024
24
cites
392
Access
View Full Text via DOI
Published in
ISSN 1319-0164
Quartile Q1
AMS Score 100
Field Medicine & Health Sciences
Publisher Elsevier / Saudi Pharmaceutical Soc
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2024
Language English
Added 23 Jul 2026